Insmed Incorporated (INSM)
USD 65.88
(-4.77%)
USD 65.88
(-4.77%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -709.62 Million USD | -48.42% |
| 2022 | -478.12 Million USD | -30.01% |
| 2021 | -367.76 Million USD | -38.66% |
| 2020 | -265.23 Million USD | -12.75% |
| 2019 | -235.24 Million USD | 23.46% |
| 2018 | -307.33 Million USD | -62.68% |
| 2017 | -188.92 Million USD | -8.95% |
| 2016 | -173.4 Million USD | -47.58% |
| 2015 | -117.49 Million USD | -34.49% |
| 2014 | -87.36 Million USD | -58.8% |
| 2013 | -55.01 Million USD | -29.64% |
| 2012 | -42.43 Million USD | 31.24% |
| 2011 | -61.71 Million USD | -662.72% |
| 2010 | -8.09 Million USD | 6.71% |
| 2009 | -8.67 Million USD | 39.81% |
| 2008 | -14.41 Million USD | 29.49% |
| 2007 | -20.43 Million USD | 62.41% |
| 2006 | -54.37 Million USD | -98.2% |
| 2005 | -27.43 Million USD | -0.03% |
| 2004 | -27.42 Million USD | -159.07% |
| 2003 | -10.58 Million USD | 71.41% |
| 2002 | -37.02 Million USD | 7.87% |
| 2001 | -40.18 Million USD | 50.71% |
| 2000 | -81.53 Million USD | -902.86% |
| 1999 | -8.13 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -185.2 Million USD | -17.66% |
| 2024 Q3 | -213.42 Million USD | -15.24% |
| 2024 Q1 | -157.4 Million USD | 11.71% |
| 2023 Q4 | -178.27 Million USD | -20.72% |
| 2023 Q1 | -157.65 Million USD | -2.86% |
| 2023 Q2 | -235.52 Million USD | -49.39% |
| 2023 Q3 | -147.66 Million USD | 37.3% |
| 2023 FY | -709.62 Million USD | -48.42% |
| 2022 Q2 | -88.31 Million USD | 12.95% |
| 2022 Q4 | -153.27 Million USD | -20.03% |
| 2022 Q3 | -127.69 Million USD | -44.59% |
| 2022 FY | -478.12 Million USD | -30.01% |
| 2022 Q1 | -101.45 Million USD | -2.4% |
| 2021 Q4 | -99.07 Million USD | 4.38% |
| 2021 Q2 | -88.56 Million USD | -5.65% |
| 2021 Q1 | -83.83 Million USD | 11.32% |
| 2021 FY | -367.76 Million USD | -38.66% |
| 2021 Q3 | -103.61 Million USD | -16.99% |
| 2020 Q4 | -94.53 Million USD | -68.15% |
| 2020 Q1 | -60.35 Million USD | -28.2% |
| 2020 FY | -265.23 Million USD | -12.75% |
| 2020 Q2 | -54.11 Million USD | 10.34% |
| 2020 Q3 | -56.22 Million USD | -3.9% |
| 2019 FY | -235.24 Million USD | 23.46% |
| 2019 Q3 | -56.48 Million USD | 9.13% |
| 2019 Q4 | -47.08 Million USD | 16.65% |
| 2019 Q1 | -69.5 Million USD | 20.76% |
| 2019 Q2 | -62.16 Million USD | 10.56% |
| 2018 Q1 | -62.75 Million USD | 3.98% |
| 2018 Q4 | -87.72 Million USD | -4.45% |
| 2018 FY | -307.33 Million USD | -62.68% |
| 2018 Q2 | -72.88 Million USD | -16.14% |
| 2018 Q3 | -83.98 Million USD | -15.23% |
| 2017 FY | -188.92 Million USD | -8.95% |
| 2017 Q4 | -65.35 Million USD | -48.25% |
| 2017 Q1 | -35.96 Million USD | 46.36% |
| 2017 Q2 | -43.51 Million USD | -20.98% |
| 2017 Q3 | -44.08 Million USD | -1.31% |
| 2016 FY | -173.4 Million USD | -47.58% |
| 2016 Q4 | -67.05 Million USD | -80.49% |
| 2016 Q3 | -37.14 Million USD | -2.81% |
| 2016 Q2 | -36.13 Million USD | -9.27% |
| 2016 Q1 | -33.06 Million USD | -1.46% |
| 2015 Q3 | -30.24 Million USD | -8.2% |
| 2015 Q2 | -27.95 Million USD | -4.67% |
| 2015 Q1 | -26.7 Million USD | -15.78% |
| 2015 FY | -117.49 Million USD | -34.49% |
| 2015 Q4 | -32.59 Million USD | -7.75% |
| 2014 FY | -87.36 Million USD | -58.8% |
| 2014 Q3 | -23.4 Million USD | -2.58% |
| 2014 Q2 | -22.81 Million USD | -26.2% |
| 2014 Q1 | -18.07 Million USD | -15.94% |
| 2014 Q4 | -23.06 Million USD | 1.44% |
| 2013 Q2 | -8.26 Million USD | 42.21% |
| 2013 Q4 | -15.59 Million USD | 7.41% |
| 2013 FY | -55.01 Million USD | -29.64% |
| 2013 Q1 | -14.3 Million USD | 9.65% |
| 2013 Q3 | -16.84 Million USD | -103.68% |
| 2012 Q2 | -9.98 Million USD | -37.43% |
| 2012 Q3 | -9.35 Million USD | 6.31% |
| 2012 Q4 | -15.83 Million USD | -69.34% |
| 2012 FY | -42.43 Million USD | 31.24% |
| 2012 Q1 | -7.26 Million USD | 18.11% |
| 2011 Q1 | -7.41 Million USD | -17.14% |
| 2011 FY | -61.71 Million USD | -662.72% |
| 2011 Q2 | -10.47 Million USD | -41.24% |
| 2011 Q3 | -34.96 Million USD | -233.81% |
| 2011 Q4 | -8.87 Million USD | 74.63% |
| 2010 Q1 | -251 Thousand USD | -173.18% |
| 2010 Q2 | -913 Thousand USD | -263.75% |
| 2010 Q3 | -598 Thousand USD | 34.5% |
| 2010 Q4 | -6.33 Million USD | -958.53% |
| 2010 FY | -8.09 Million USD | 6.71% |
| 2009 Q1 | -6.94 Million USD | -85.85% |
| 2009 Q3 | -764 Thousand USD | 41.5% |
| 2009 Q4 | 343 Thousand USD | 144.9% |
| 2009 FY | -8.67 Million USD | 39.81% |
| 2009 Q2 | -1.3 Million USD | 81.2% |
| 2008 Q2 | -4.43 Million USD | 7.57% |
| 2008 Q4 | -3.73 Million USD | -98.2% |
| 2008 Q1 | -4.79 Million USD | -43.48% |
| 2008 FY | -14.41 Million USD | 29.49% |
| 2008 Q3 | -1.88 Million USD | 57.47% |
| 2007 Q4 | -3.34 Million USD | 18.89% |
| 2007 Q3 | -4.12 Million USD | -60.49% |
| 2007 Q2 | -2.56 Million USD | 75.31% |
| 2007 Q1 | -10.4 Million USD | 51.4% |
| 2007 FY | -20.43 Million USD | 62.41% |
| 2006 Q3 | -12.72 Million USD | -36.47% |
| 2006 Q2 | -9.32 Million USD | 14.62% |
| 2006 Q4 | -21.4 Million USD | -68.22% |
| 2006 Q1 | -10.92 Million USD | -54.59% |
| 2006 FY | -54.37 Million USD | -98.2% |
| 2005 Q1 | -5.52 Million USD | 6.12% |
| 2005 FY | -27.43 Million USD | -0.03% |
| 2005 Q2 | -6.95 Million USD | -25.86% |
| 2005 Q3 | -7.89 Million USD | -13.6% |
| 2005 Q4 | -7.06 Million USD | 10.54% |
| 2004 Q2 | -9.06 Million USD | -87.38% |
| 2004 Q1 | -4.83 Million USD | -93.09% |
| 2004 FY | -27.42 Million USD | -159.07% |
| 2004 Q4 | -5.88 Million USD | 23.07% |
| 2004 Q3 | -7.64 Million USD | 15.6% |
| 2003 Q2 | -3.31 Million USD | -43.98% |
| 2003 FY | -10.58 Million USD | 71.41% |
| 2003 Q1 | -2.3 Million USD | 87.64% |
| 2003 Q4 | -2.5 Million USD | -1.46% |
| 2003 Q3 | -2.46 Million USD | 25.51% |
| 2002 Q3 | -4.81 Million USD | 33.89% |
| 2002 Q4 | -18.62 Million USD | -287.03% |
| 2002 Q2 | -7.27 Million USD | -15.37% |
| 2002 Q1 | -6.3 Million USD | 38.38% |
| 2002 FY | -37.02 Million USD | 7.87% |
| 2001 Q4 | -10.23 Million USD | -14.09% |
| 2001 FY | -40.18 Million USD | 50.71% |
| 2001 Q2 | -9.62 Million USD | 15.13% |
| 2001 Q1 | -11.34 Million USD | -26.49% |
| 2001 Q3 | -8.97 Million USD | 6.8% |
| 2000 Q1 | -11.42 Million USD | 0.0% |
| 2000 FY | -81.53 Million USD | -902.86% |
| 2000 Q2 | -55.6 Million USD | -386.87% |
| 2000 Q4 | -8.96 Million USD | -61.75% |
| 2000 Q3 | -5.54 Million USD | 90.03% |
| 1999 Q2 | -1.67 Million USD | -6.08% |
| 1999 Q1 | -1.58 Million USD | 0.0% |
| 1999 FY | -8.13 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -199.159% |
| Alkermes plc | 414.12 Million USD | 271.357% |
| Agenus Inc. | -159.54 Million USD | -344.77% |
| Aptorum Group Limited | -10.52 Million USD | -6643.36% |
| Ardelyx, Inc. | -63.27 Million USD | -1021.477% |
| Dyadic International, Inc. | -8.22 Million USD | -8522.704% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -59432.383% |
| Lantern Pharma Inc. | -17.87 Million USD | -3869.365% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -3432.272% |
| Novavax, Inc. | -566.51 Million USD | -25.263% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -872.37% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -763.334% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -3554.378% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -6618.035% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -1235.732% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -86.5% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2819.478% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1773.897% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -450.149% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -745.659% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -3945.989% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1512.42% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -2756.327% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -410.408% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -151.484% |
| AlloVir, Inc. | -181.33 Million USD | -291.343% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -246.156% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -2325.408% |
| Bicycle Therapeutics plc | -189.94 Million USD | -273.594% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -313.097% |
| ChromaDex Corporation | -5.59 Million USD | -12574.156% |
| Chimerix, Inc. | -93.06 Million USD | -662.506% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1474.242% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -511.436% |
| CRISPR Therapeutics AG | -222.53 Million USD | -218.879% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1522.521% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -272.486% |
| Fortress Biotech, Inc. | -142.34 Million USD | -398.536% |
| Fortress Biotech, Inc. | -142.34 Million USD | -398.536% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -626.376% |
| ImmuCell Corporation | -5.74 Million USD | -12245.448% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -427.882% |
| Immix Biopharma, Inc. | -16.14 Million USD | -4296.388% |
| Incyte Corporation | 620.52 Million USD | 214.359% |
| Innoviva, Inc. | 176.7 Million USD | 501.579% |
| IO Biotech, Inc. | -91.44 Million USD | -676.031% |
| Jaguar Health, Inc. | -34.29 Million USD | -1969.423% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -317.572% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 6042.271% |
| ContextLogic Inc. | -328 Million USD | -116.349% |
| MiMedx Group, Inc. | 37.11 Million USD | 2011.914% |
| MEI Pharma, Inc. | 14.54 Million USD | 4979.838% |
| NextCure, Inc. | -67.63 Million USD | -949.168% |
| Onconetix, Inc. | -36.03 Million USD | -1869.291% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1601.17% |
| Opthea Limited | -191.84 Million USD | -269.9% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -25687.468% |
| Vaxcyte, Inc. | -468.04 Million USD | -51.616% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1548.559% |
| Precigen, Inc. | -88.92 Million USD | -698.023% |
| Pharming Group N.V. | -4.87 Million USD | -14442.875% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -324.133% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -2284.817% |
| PureTech Health plc | -146.19 Million USD | -385.384% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -3363.111% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -201.202% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2819.478% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -158.983% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -2321.519% |
| Acelyrin, Inc. | -422.06 Million USD | -68.132% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -5503035.338% |
| Summit Therapeutics Inc. | -89.73 Million USD | -690.793% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1814.596% |
| Senti Biosciences, Inc. | -92.72 Million USD | -665.285% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -518.287% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1461.505% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1970.873% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -17901.455% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -22342.315% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -2049.014% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -8247.559% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -943.629% |
| Seer, Inc. | -103.46 Million USD | -585.874% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -979.131% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -886.51% |
| ESSA Pharma Inc. | -32.13 Million USD | -2108.327% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1706.8% |
| GT Biopharma, Inc. | -13.57 Million USD | -5127.062% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -223.703% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1434.127% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 917.428% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -1150.244% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -1277.754% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -7040.786% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -40.711% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -10187.417% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -1299.85% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -173.292% |
| Aptose Biosciences Inc. | -52.35 Million USD | -1255.386% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -4820.859% |
| Soligenix, Inc. | -7.69 Million USD | -9118.388% |
| Century Therapeutics, Inc. | -146.54 Million USD | -384.234% |
| Kura Oncology, Inc. | -165.8 Million USD | -327.991% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -659.299% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -8430.184% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -28495.054% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -10844.263% |
| Autolus Therapeutics plc | -195.02 Million USD | -263.859% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -738.237% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -863.354% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -3257.587% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -212.562% |
| GRI Bio, Inc. | -11.38 Million USD | -6131.896% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -15614.588% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -440.902% |
| IGM Biosciences, Inc. | -263.46 Million USD | -169.348% |
| INmune Bio, Inc. | -29.74 Million USD | -2286.019% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -541.528% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1763.743% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -4340.891% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -4399.612% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -1061.455% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -559.982% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -157.105% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -249.227% |
| Verastem, Inc. | -92.08 Million USD | -670.629% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -1405.518% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -285.363% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -499.448% |
| Histogen Inc. | -10.64 Million USD | -6567.537% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -4486.529% |
| Surrozen, Inc. | -45.78 Million USD | -1450.079% |
| Organovo Holdings, Inc. | -15.08 Million USD | -4603.871% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -13840.925% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -1097.045% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1283.448% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -2707.065% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -9197.008% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -314.3% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -1364.718% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -807.392% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -4562.22% |
| Apollomics, Inc. | -54.83 Million USD | -1194.135% |
| Amarin Corporation plc | -67.58 Million USD | -949.929% |
| Mesoblast Limited | -58.79 Million USD | -1106.97% |
| Turnstone Biologics Corp. | -59.03 Million USD | -1102.104% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -328.699% |
| Synaptogenix, Inc. | -8.31 Million USD | -8435.464% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -4765.117% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -673.932% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -14710.206% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -7935.411% |
| Exelixis, Inc. | 170.88 Million USD | 515.265% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1754.65% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -357.637% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -37.226% |
| NLS Pharmaceutics AG | -11.8 Million USD | -5910.182% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -8724.102% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -2265.972% |
| Gritstone bio, Inc. | -154.63 Million USD | -358.907% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -930.519% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -4044.273% |
| Avid Bioservices, Inc. | -18.67 Million USD | -3699.261% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -4422.853% |
| MediWound Ltd. | -15.29 Million USD | -4541.112% |
| OmniAb, Inc. | -69.41 Million USD | -922.236% |
| Alector, Inc. | -151.74 Million USD | -367.659% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -557.165% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -1260.792% |
| Zai Lab Limited | -366.57 Million USD | -93.584% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -124.014% |
| Aura Biosciences, Inc. | -84.99 Million USD | -734.943% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -189.055% |
| Immunic, Inc. | -99.22 Million USD | -615.183% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -395.694% |
| Veracyte, Inc. | -85.79 Million USD | -727.118% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -151.806% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -4893.849% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -10202.431% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -3676.089% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 222.65% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -2687.986% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1928.839% |
| TG Therapeutics, Inc. | 20.63 Million USD | 3539.277% |
| Galecto, Inc. | -39.9 Million USD | -1678.288% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1586.614% |
| Fortrea Holdings Inc. | 63.1 Million USD | 1224.605% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -405.27% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -2357.324% |
| XBiotech Inc. | -37.51 Million USD | -1791.832% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -930.519% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -957.25% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -557.633% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2664.202% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -1231.581% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -24.669% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -804.074% |
| Vaxxinity, Inc. | -58.28 Million USD | -1117.511% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -584.247% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -3088.881% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -721.174% |
| NexImmune, Inc. | -29.19 Million USD | -2330.852% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -12526.501% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -4766.659% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 117.534% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -2687.329% |
| Scopus BioPharma Inc. | -11.71 Million USD | -5957.477% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -458.488% |
| Ainos, Inc. | -13.2 Million USD | -5273.351% |
| Pluri Inc. | -22.15 Million USD | -3102.572% |
| Prothena Corporation plc | -191.03 Million USD | -271.462% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -414.08% |
| Celularity Inc. | -192.28 Million USD | -269.045% |
| Rallybio Corporation | -78.93 Million USD | -799.035% |
| Cue Biopharma, Inc. | -52.14 Million USD | -1260.766% |
| MeiraGTx Holdings plc | -137.06 Million USD | -417.745% |
| Omeros Corporation | -164.53 Million USD | -331.305% |
| Humacyte, Inc. | -100.04 Million USD | -609.293% |
| Immunocore Holdings plc | -59.64 Million USD | -1089.67% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -3723.622% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2798.444% |
| Blueprint Medicines Corporation | -486.27 Million USD | -45.93% |
| CalciMedica, Inc. | -21.87 Million USD | -3144.005% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -850.477% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -439.701% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -314.271% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -117.077% |
| Pulmatrix, Inc. | -14.74 Million USD | -4714.288% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1885.245% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -698.535% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -37.714% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -950.504% |
| Cytokinetics, Incorporated | -496.2 Million USD | -43.011% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1961.728% |
| Nutriband Inc. | -4.87 Million USD | -14465.615% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1527.097% |
| Vor Biopharma Inc. | -126.03 Million USD | -463.034% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 116.729% |
| Evogene Ltd. | -26.39 Million USD | -2588.894% |
| ProKidney Corp. | -151.52 Million USD | -368.332% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -999.599% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -9125.217% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | -16.836% |
| CorMedix Inc. | -48.95 Million USD | -1349.465% |
| BioLineRx Ltd. | -49.69 Million USD | -1327.991% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -521.536% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1763.905% |
| Atai Life Sciences N.V. | -125.47 Million USD | -465.57% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -769.221% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -771.68% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -185.004% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -2208.478% |
| MediciNova, Inc. | -9.9 Million USD | -7067.748% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -461.533% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -9698.136% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2553.508% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -206.104% |
| Biomea Fusion, Inc. | -126.13 Million USD | -462.592% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -103.097% |
| Mereo BioPharma Group plc | -28.41 Million USD | -2397.276% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -271.359% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -208.595% |
| Absci Corporation | -115.51 Million USD | -514.315% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2472.32% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -528.728% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -193.038% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -2716.423% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -241.176% |
| Allakos Inc. | -196.05 Million USD | -261.951% |
| Imunon, Inc. | -21.03 Million USD | -3274.282% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -541.244% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 761.459% |
| BioAtla, Inc. | -129.68 Million USD | -447.184% |
| NLS Pharmaceutics AG | -11.8 Million USD | -5910.182% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -4379.114% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -116.523% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1599.377% |
| XOMA Corporation | -41.84 Million USD | -1595.723% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -574.312% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -484.078% |
| aTyr Pharma, Inc. | -54.91 Million USD | -1192.132% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -711.678% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -310.497% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -178.886% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -3205.814% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -8540.535% |
| Akari Therapeutics, Plc | -16.8 Million USD | -4122.456% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -8024592.894% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 310.213% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -10760.478% |
| UroGen Pharma Ltd. | -65.53 Million USD | -982.803% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -694.85% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -9670.409% |
| Orgenesis Inc. | -53.63 Million USD | -1223.04% |
| Entera Bio Ltd. | -8.89 Million USD | -7881.397% |
| GH Research PLC | -41.22 Million USD | -1621.474% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -2660.331% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -754.425% |
| Xencor, Inc. | -138.63 Million USD | -411.852% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -13666.894% |
| Replimune Group, Inc. | -234.77 Million USD | -202.26% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -3201.95% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -4986.196% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -10760.478% |
| Portage Biotech Inc. | -18.25 Million USD | -3787.723% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -9698.136% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -576.085% |
| OncoCyte Corporation | -25.13 Million USD | -2723.146% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -6177.178% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -6093.787% |
| Purple Biotech Ltd. | 22.27 Million USD | 3286.323% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -9346.565% |
| scPharmaceuticals Inc. | -55.39 Million USD | -1181.006% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -3655.093% |
| HilleVax, Inc. | -133.34 Million USD | -432.173% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -5789.501% |
| Tharimmune, Inc. | -9.45 Million USD | -7405.124% |
| Genprex, Inc. | -31.07 Million USD | -2183.549% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -277.072% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -2161.612% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -92661.569% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -12928.026% |
| OKYO Pharma Limited | -15.74 Thousand USD | -4505539.144% |
| Savara Inc. | -60 Million USD | -1082.572% |
| Curis, Inc. | -48.33 Million USD | -1368.232% |
| Daré Bioscience, Inc. | -30.83 Million USD | -2201.001% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -13501.455% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -9651.628% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -2504.132% |
| BeiGene, Ltd. | -1.2 Billion USD | 41.243% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -3458.931% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -45.658% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -657.726% |
| Erasca, Inc. | -141.52 Million USD | -401.414% |
| bluebird bio, Inc. | -244.26 Million USD | -190.518% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -15575.504% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 464.957% |
| DBV Technologies S.A. | -76.43 Million USD | -828.441% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -15575.504% |
| Moderna, Inc. | -4.23 Billion USD | 83.26% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1565.437% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -11057.642% |
| Molecular Templates, Inc. | -10.46 Million USD | -6680.298% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -955.41% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -88.358% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -395.165% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -1264.849% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -359.18% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -240.953% |
| MacroGenics, Inc. | -168.24 Million USD | -321.784% |
| RenovoRx, Inc. | -11.39 Million USD | -6126.974% |
| Adicet Bio, Inc. | -152.03 Million USD | -366.743% |
| Prime Medicine, Inc. | -191.29 Million USD | -270.965% |
| Aditxt, Inc. | -26.06 Million USD | -2622.793% |
| Adagene Inc. | -23.71 Million USD | -2891.695% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -9607.476% |
| Quantum-Si incorporated | -111.17 Million USD | -538.319% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -2142.246% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4767.865% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 681.594% |
| SciSparc Ltd. | -5.77 Million USD | -12192.153% |
| Vericel Corporation | -6.46 Million USD | -10878.125% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -8097.453% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2969.373% |
| Generation Bio Co. | -138.56 Million USD | -412.132% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -754.662% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -720.756% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -194.327% |
| Invivyd, Inc. | -207.78 Million USD | -241.523% |
| Relay Therapeutics, Inc. | -373 Million USD | -90.248% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -7466.516% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 3403.505% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -6798.279% |
| 2seventy bio, Inc. | -216.7 Million USD | -227.465% |
| ADMA Biologics, Inc. | 21.63 Million USD | 3380.446% |
| Clene Inc. | -40.54 Million USD | -1650.434% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2847.214% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -1195.032% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2553.508% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -102.716% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1831.9% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 4513.921% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -584.293% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1987.013% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -316.746% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -3.7% |
| Evaxion Biotech A/S | -22.19 Million USD | -3096.946% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -761.385% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -218.041% |
| Trevena, Inc. | -35.28 Million USD | -1910.956% |
| Surrozen, Inc. | -45.78 Million USD | -1450.079% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -787.643% |
| Cingulate Inc. | -22.75 Million USD | -3017.976% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 9571.783% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1488.703% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -8518.303% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -591.927% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -867.07% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -1043.194% |
| Clearmind Medicine Inc. | -8.74 Million USD | -8018.037% |
| Kronos Bio, Inc. | -121.83 Million USD | -482.472% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -831.317% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -24094.669% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -603.806% |
| Statera Biopharma, Inc. | -98.34 Million USD | -621.577% |
| ImmunityBio, Inc. | -362.25 Million USD | -95.894% |
| Korro Bio, Inc. | -84.53 Million USD | -739.456% |
| Kineta, Inc. | -15.72 Million USD | -4413.299% |
| BioVie Inc. | -32.17 Million USD | -2105.206% |
| Codexis, Inc. | -68.06 Million USD | -942.51% |
| Celularity Inc. | -192.28 Million USD | -269.045% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -218.778% |
| Celcuity Inc. | -66.23 Million USD | -971.452% |
| Virax Biolabs Group Limited | -6.49 Million USD | -10823.25% |
| Cibus, Inc. | -318.88 Million USD | -122.535% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1550.293% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1996.756% |
| IN8bio, Inc. | -30.33 Million USD | -2239.144% |
| Kodiak Sciences Inc. | -277.32 Million USD | -155.886% |
| Annexon, Inc. | -143.72 Million USD | -393.746% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -473.245% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -997.711% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2926.898% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -100.612% |
| Eyenovia, Inc. | -25.4 Million USD | -2693.094% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 2274.099% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -12658.468% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -796.751% |
| Arcellx, Inc. | -89.88 Million USD | -689.526% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1462.64% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -417.194% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -2181.096% |
| Moolec Science SA | -6.65 Million USD | -10564.965% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -1060.695% |
| Geron Corporation | -193.94 Million USD | -265.892% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1540.64% |
| Royalty Pharma plc | 1.49 Billion USD | 147.557% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -332.272% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -7507.592% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -3141.091% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -315.09% |
| Humacyte, Inc. | -100.04 Million USD | -609.293% |
| Structure Therapeutics Inc. | -102.77 Million USD | -590.466% |
| 89bio, Inc. | -151.2 Million USD | -369.317% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -785.571% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -4780.509% |
| Genelux Corporation | -24.16 Million USD | -2836.586% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1991.873% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -313.174% |
| Notable Labs, Ltd. | -14.65 Million USD | -4741.55% |
| Liquidia Corporation | -73.38 Million USD | -867.004% |
| Mustang Bio, Inc. | -50.72 Million USD | -1298.939% |
| Immunovant, Inc. | -282.7 Million USD | -151.009% |
| Quantum-Si incorporated | -111.17 Million USD | -538.319% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -808.577% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -3236.747% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -595.63% |
| Acasti Pharma Inc. | -11.31 Million USD | -6173.214% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2995.95% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -4340.891% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -231.517% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -19240.749% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -4366.99% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -2333.81% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1614.735% |
| PepGen Inc. | -84.76 Million USD | -737.159% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -2294.877% |
| United Therapeutics Corporation | 1.18 Billion USD | 159.889% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2999.21% |
| Solid Biosciences Inc. | -104.31 Million USD | -580.272% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -2062.959% |
| Immuneering Corporation | -58.41 Million USD | -1114.845% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -13840.925% |
| Silo Pharma, Inc. | -3.85 Million USD | -18305.111% |
| Belite Bio, Inc | -31.66 Million USD | -2140.83% |
| XOMA Corporation | -41.84 Million USD | -1595.723% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -950.986% |
| Bionomics Limited | -17.89 Billion USD | 96.034% |
| Apogee Therapeutics, Inc. | -93 Million USD | -663.014% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 2088.862% |
| uniQure N.V. | -282.87 Million USD | -150.866% |
| Cassava Sciences, Inc. | -105.95 Million USD | -569.73% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -9607.476% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -447.957% |
| Forte Biosciences, Inc. | -32.48 Million USD | -2084.406% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -8440.702% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -2314.104% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -12658.468% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -4893.849% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -7883.193% |
| Altimmune, Inc. | -95.92 Million USD | -639.741% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -865.556% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 2088.862% |
| Compugen Ltd. | -12.99 Million USD | -5362.023% |
| Peak Bio, Inc. | -1356.23 USD | -52323325.968% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -1330.582% |
| Benitec Biopharma Inc. | -22.49 Million USD | -3055.296% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -192.867% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -2285.618% |
| Zura Bio Limited | -62.63 Million USD | -1032.9% |
| PolyPid Ltd. | -22.86 Million USD | -3003.275% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -4259.953% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -2285.618% |
| Instil Bio, Inc. | -159.16 Million USD | -345.832% |
| argenx SE | -425.04 Million USD | -66.952% |
| Immunome, Inc. | -109.53 Million USD | -547.883% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -1309.022% |
| Verona Pharma plc | -67.83 Million USD | -946.169% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -2623.047% |
| Shattuck Labs, Inc. | -91.95 Million USD | -671.693% |
| CervoMed Inc. | -7.81 Million USD | -8982.754% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -870.628% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -5227.123% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1373.048% |
| Moolec Science SA | -6.65 Million USD | -10564.965% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -4214.245% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -424.768% |
| AnaptysBio, Inc. | -164.41 Million USD | -331.617% |
| Design Therapeutics, Inc. | -78.19 Million USD | -807.566% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -715.278% |
| NeurAxis, Inc. | -6.66 Million USD | -10547.859% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1652.206% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1838.127% |
| Achilles Therapeutics plc | -75.25 Million USD | -842.962% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -2623.047% |
| 180 Life Sciences Corp. | -13.47 Million USD | -5165.264% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 13862.281% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -24094.669% |
| Nutriband Inc. | -4.87 Million USD | -14465.615% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -540.572% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -1179.781% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -1295.912% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -973.581% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -1211.133% |
| Palisade Bio, Inc. | -13.07 Million USD | -5329.426% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1462.743% |
| Beam Therapeutics Inc. | -176.48 Million USD | -302.089% |
| Neurogene Inc. | -55.58 Million USD | -1176.696% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -550.115% |
| AEON Biopharma, Inc. | -48.42 Million USD | -1365.291% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -633.767% |
| Sesen Bio, Inc. | -25.9 Million USD | -2638.917% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -749.556% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -5537.816% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -54.079% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -879.619% |
| Athira Pharma, Inc. | -125.46 Million USD | -465.592% |
| Vaccinex, Inc. | -22.88 Million USD | -3000.835% |
| HCW Biologics Inc. | -25.71 Million USD | -2659.348% |
| XOMA Corporation | -41.84 Million USD | -1595.723% |
| Nektar Therapeutics | -137.42 Million USD | -416.373% |
| Arvinas, Inc. | -401.5 Million USD | -76.744% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -8024592.894% |
| Merus N.V. | -156.54 Million USD | -353.299% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -607.779% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1949.757% |
| Rezolute, Inc. | -70.42 Million USD | -907.662% |
| Clene Inc. | -40.54 Million USD | -1650.434% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -4232.675% |
| BeyondSpring Inc. | -23.11 Million USD | -2970.113% |
| Synlogic, Inc. | -55.16 Million USD | -1186.463% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -3857.979% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -6456.042% |
| Peak Bio, Inc. | -1356.23 USD | -52323325.968% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1652.033% |
| Krystal Biotech, Inc. | -109.72 Million USD | -546.72% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -447.805% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -106.88% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -14852.234% |
| MannKind Corporation | 8.67 Million USD | 8277.299% |
| Ikena Oncology, Inc. | -75.41 Million USD | -840.936% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -7255.924% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -955.52% |
| Gossamer Bio, Inc. | -183.75 Million USD | -286.172% |
| CohBar, Inc. | -12.38 Million USD | -5628.197% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -1298.995% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2472.32% |
| Legend Biotech Corporation | -439.48 Million USD | -61.468% |
| Mural Oncology plc | -194.63 Million USD | -264.588% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -956.888% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -4295.256% |
| Disc Medicine, Inc. | -91.12 Million USD | -678.739% |
| Champions Oncology, Inc. | -7.35 Million USD | -9546.9% |
| REGENXBIO Inc. | -268.12 Million USD | -164.659% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -6520.765% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -1172.735% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1721.392% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -520.536% |
| Vaxart, Inc. | -83.34 Million USD | -751.412% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -8228.936% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1558.234% |
| Cellectis S.A. | -106.62 Million USD | -565.528% |
| Longeveron Inc. | -21.02 Million USD | -3274.511% |
| Repare Therapeutics Inc. | -116.22 Million USD | -510.568% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -164.96% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -838.1% |
| Revolution Medicines, Inc. | -487.18 Million USD | -45.658% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -10567.859% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1514.474% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -851.369% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -919.065% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -6344.701% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 116.474% |
| Denali Therapeutics Inc. | -196.69 Million USD | -260.767% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -8097.453% |
| Veru Inc. | -93.78 Million USD | -656.674% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2941.819% |
| Cingulate Inc. | -22.75 Million USD | -3017.976% |
| Passage Bio, Inc. | -108.38 Million USD | -554.703% |
| Context Therapeutics Inc. | -25.07 Million USD | -2730.283% |
| Exicure, Inc. | -14.99 Million USD | -4632.102% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -244.372% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1647.933% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -7202.98% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -284.919% |
| Nuvalent, Inc. | -149.49 Million USD | -374.692% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -8536.588% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -699.75% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -3315.933% |
| OmniAb, Inc. | -69.41 Million USD | -922.236% |
| Anew Medical, Inc. | -1.3 Million USD | -54451.367% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -5456.542% |
| Lipocine Inc. | -17.93 Million USD | -3857.547% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -935.754% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -831.855% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1763.743% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1695.294% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -3070.238% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -22.381% |
| Ocugen, Inc. | -65.53 Million USD | -982.886% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -655.999% |
| Q32 Bio Inc. | -92.1 Million USD | -670.478% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -3209.977% |
| Alumis Inc. Common Stock | -158.17 Million USD | -348.636% |
| Equillium, Inc. | -14.52 Million USD | -4786.558% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -1037.112% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -8878.801% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -3661.579% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -1411.418% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -554.238% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -5828.363% |
| Dominari Holdings Inc. | -21.79 Million USD | -3155.763% |
| Edesa Biotech, Inc. | -9.22 Million USD | -7594.293% |
| vTv Therapeutics Inc. | -25.5 Million USD | -2682.629% |
| Bio-Techne Corporation | 206.68 Million USD | 443.335% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -81.264% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 469.539% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -436.47% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1748.418% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -369.637% |
| Nkarta, Inc. | -131.65 Million USD | -439.025% |
| BioCardia, Inc. | -11.64 Million USD | -5994.349% |
| Iterum Therapeutics plc | -47.46 Million USD | -1394.957% |